[1]
«An Open Label Clinical Study Evaluating the Effectiveness of a Cryptolepis sanguinolenta based Herbal Antimalarial Agent», AJBR, vol. 22, fasc. 3, pp. 257–262, dic. 2019, Consultato: 13 giugno 2026. [Online]. Disponibile su: https://www.ojshostng.com/index.php/ajbr/article/view/1321